Showing 3211-3220 of 4063 results for "".
- Staar Surgical Announces Agreement in US with IQ Laser Visionhttps://modernod.com/news/staar-surgical-announces-agreement-in-us-with-iq-laser-vision/2482269/Staar Surgical announced a strategic agreement with IQ Laser Vision, which has locations across California and Texas. IQ Laser Vision will make EVO ICL lenses a primary option for patients seeking surgical vision correction within the range of -3D to -20D. IQ Laser V
- iOR Partners Co-Founder and Chairman of the Board, Daniel S. Durrie, MD, Retireshttps://modernod.com/news/ior-partners-co-founder-and-chairman-of-the-board-daniel-s-durrie-md-retires/2482267/iOR Partners announced the retirement of Daniel S. Durrie, MD, as Chairman of the Board of Directors. Dr. Durrie co-founded iOR Partners, a provider of ophthalmic office-based surgery (OBS), in 2018. iOR's model provides surgeons with turnkey OBS suites and support service
- Johnson & Johnson to Debut EYE-RD Global Registry at ARVOhttps://modernod.com/news/johnson-johnson-to-debut-eye-rd-global-registry-at-arvo/2482261/Johnson & Johnson announced that eight company-sponsored presentations will be featured during the Association for Research in Vision and Ophthalmology (ARVO) 2024 Annual Meeting taking place in Seattle from May 5–9, 2024. The company's two oral presentations wil
- Safilo North America Appoints New Leaderhttps://modernod.com/news/safilo-north-america-appoints-new-leader/2482258/Safilo North America announced the appointment of Gabriele Cusani Sodano as president and chief commercial officer, effective April 2024. The company says Mr. Cusani brings a wealth of experience and a proven track record to succeed in this new role, which will focus on accelerating the implement
- Bausch + Lomb Presents New Data at the Association for Research in Vision and Ophthalmology Annual Meetinghttps://modernod.com/news/bausch-lomb-presents-new-data-at-the-association-for-research-in-vision-and-ophthalmology-annual-meeting/2482250/Bausch + Lomb announced the presentation of 21 scientific poster presentations during the Association for Research in Vision and Ophthalmology (ARVO) annual meeting, which will take place in Seattle on May 5-9, 2024. The posters highlight the results of studies evaluating consumer,
- Aldeyra Therapeutics Announces Planned Pivotal Clinical Trial for RP Drug Candidatehttps://modernod.com/news/aldeyra-therapeutics-announces-planned-pivotal-clinical-trial-for-retinitis-pigmentosa-drug-candidate/2482247/Aldeyra Therapeutics hosted the Aldeyra 2024 Research & Development Day with investors and financial analysts in New York City on April 25 where it presented recent pipeline developments relating to the RASP modulation platform and ADX-2191 for the treatment of retinitis pigmentosa.
- New Ocular Telehealth Program Enables Diabetic Retinopathy Screeninghttps://modernod.com/news/new-ocular-telehealth-program-enables-diabetic-retinopathy-screening/2482241/Visionix USA and 20/20NOW have launched an ocular telehealth program to enable diabetic retinopathy screening. The new technology will be presented at the American Telemedicine Association (ATA)’s 2024 Nexus Conference and Expo in Arizona in May. Visionix and 20/20NOW will be offe
- Robotic Cataract Surgery Using ForSight Robotics’ Oryom Platform Presented for the First Time at ASCRShttps://modernod.com/news/robotic-cataract-surgery-using-forsight-robotics-oryom-platform-presented-for-the-first-time-at-the-ascrs-annual-meeting/2482229/Robotic cataract surgery using ForSight Robotics’ Oryom platform on a porcine eye was presented at the 2024 ASCRS annual meeting by David F. Chang, MD, marking the debut of this technology at a professional conference. During
- Oasis Medical Introduces SOFT PLUG Extended Duration 180-T Tapered Plughttps://modernod.com/news/orasis-introduces-soft-plug-extended-duration-180-t-tapered-plug/2482222/Oasis Medical has launched the SOFT PLUG Extended Duration 180-T Tapered Plug. SOFT PLUG Extended Duration 180-T Tapered Plugs are designed with a .25mm tapered end for ease of insertion into the punctal opening, according to Oasis. The plug then gradu
- Oculis Announces Positive Results from Phase 3 Trial of Once Daily Treatment for Inflammation and Pain Following Cataract Surgeryhttps://modernod.com/news/oculis-announces-positive-results-from-phase-3-trial-of-once-daily-ocs-01-for-treatment-of-inflammation-and-pain-following-cataract-surgery/2482221/Oculis announced positive results from the phase 3 OPTIMIZE-1 trial of OCS-01 for the treatment of inflammation and pain following cataract surgery at the 2024 ASCRS annual meeting in Boston. Eric Donnenfeld, MD, presented the “Once Daily OCS-01, an OPTIREACH F